LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo tested to fight lung cancer in the brain
Disease control TerminatedThis study tested whether adding the drug pembrolizumab to standard chemotherapy could help patients with a type of lung cancer that had spread to their brain but wasn't causing symptoms. The goal was to see if this approach could control the cancer in the brain and body, help pa…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo tested in fight against advanced lung cancer
Disease control TerminatedThis study tested a new oral drug, SLC-391, combined with the immunotherapy drug pembrolizumab in people with advanced non-small cell lung cancer (NSCLC). The first part aimed to find a safe dose for the combination. The second part aimed to see if the combination could help stop…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC